The long-awaited list of the first 10 Part D drugs to be included in the new Medicare Price Negotiation process includes the commonly prescribed rheumatology drugs Enbrel and Stelara. Initial negotiations with the drug manufacturers will begin this fall.

ACR on the Hill: Members Ask Congress to Reduce Barriers to Care
In late September, 80 rheumatologists, rheumatology professionals and patients living with rheumatic disease convened in Washington, D.C., for the ACR’s annual Advocates for Arthritis conference, where they marshaled in support of legislation that would reduce current barriers to care for patients.
FDA Grants Interchangeable Designation to Pfizer’s Abrilada, Biosimilar to AbbVie’s Humira
On Oct. 5, Pfizer announced that Abrilada (adalimumab-afzb), its biosimilar to Humira (adalimumab), had received an interchangeable designation from the U.S. Food & Drug Administration (FDA).
Glucocorticoid Use at Any Dose Increases Fracture Risk
The accepted wisdom is that the negative effects of glucocorticoids on bone depend on the dose and treatment duration. Adami et al. conducted this study to determine, in a real-life setting, the risk of fragility fracture associated with the dose of glucocorticoids in patients with inflammatory rheumatic musculoskeletal diseases.
The ACR Launches Rheumatoid Arthritis Measures Toolkit
The new resource offers standardized outcome measures for providers who treat patients with RA, as well as training materials for medical staff to guide accurate and efficient data collection. It also includes video tutorials and sample workflows for different EHR systems.

Updates from the ACR Insurance Subcommittee Chair
The Insurance Subcommittee is working to address coverage and reimbursement challenges facing rheumatology practices. Recent activities include efforts to avoid increased administrative burden associated with specialty medications, support payer coverage of musculoskeletal ultrasounds and protect patient access to biologics.

Rheumatologists Treat Patients While Ukraine Is at War
Rheumatologists living in Ukraine press on with their work of treating patients despite the ongoing war that began with a Russian military invasion.
2024 Proposed Rule for the Quality Payment Program Released
See key changes for the Merit-Based Incentive Payment System for the 2024 performance year as outlined in the proposed rule.

Implications of Florida’s Electronic Health Records Data Storage Law
Healthcare is a high-priority target for cyber criminals. State-level measures, such as a new Florida law, fail to address the root problems of data security but may affect how providers manage patient data.

Guideline for Integrative RA Interventions Released
Discussions between clinicians and their patients about complementary aspects of their care just got easier with the release of the 2022 ACR Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.
- « Previous Page
- 1
- …
- 44
- 45
- 46
- 47
- 48
- …
- 332
- Next Page »